NASDAQ:DOXAmdocs Stock Price, Forecast & News

Amdocs' stock was trading at $61.42 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, DOX shares have decreased by 1.8% and is now trading at $60.30. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Amdocs.

Amdocs is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Amdocs.

Amdocs Limited (NASDAQ:DOX) posted its quarterly earnings results on Thursday, May, 7th. The technology company reported $1.08 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.06 by $0.02. The technology company had revenue of $1.05 billion for the quarter, compared to the consensus estimate of $1.04 billion. Amdocs had a return on equity of 16.03% and a net margin of 11.98%. The firm's quarterly revenue was up 2.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.06 earnings per share. View Amdocs' earnings history.

Amdocs declared a quarterly dividend on Thursday, May 7th. Investors of record on Tuesday, June 30th will be given a dividend of $0.327 per share on Friday, July 24th. This represents a $1.31 dividend on an annualized basis and a yield of 2.17%. The ex-dividend date is Monday, June 29th. View Amdocs' dividend history.

Amdocs updated its third quarter earnings guidance on Thursday, May, 7th. The company provided earnings per share guidance of $1.00 to $1.08 for the period, compared to the Thomson Reuters consensus estimate of $1.16. The company issued revenue guidance of $990 million to $1.040 billion, compared to the consensus revenue estimate of $1.05 billion.

5 analysts have issued 1-year price objectives for Amdocs' stock. Their forecasts range from $72.00 to $85.00. On average, they expect Amdocs' stock price to reach $76.40 in the next twelve months. This suggests a possible upside of 26.7% from the stock's current price. View analysts' price targets for Amdocs.

News articles about DOX stock have been trending very negative on Thursday, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Amdocs earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned media stories about the technology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news about Amdocs.

Some companies that are related to Amdocs include Accenture (ACN), IBM (IBM), Cognizant Technology Solutions (CTSH), EPAM Systems (EPAM), Leidos (LDOS), Booz Allen Hamilton (BAH), Gartner (IT), Caci International (CACI), Mantech International (MANT), Teradata (TDC), Virtusa (VRTU), Unisys (UIS), Forrester Research (FORR), The Hackett Group (HCKT) and Servicesource International (SREV). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include AbbVie (ABBV), Comcast (CMCSA), AT&T (T), Walt Disney (DIS), Gilead Sciences (GILD), Home Depot (HD), Intel (INTC), Pfizer (PFE), Verizon Communications (VZ) and Cisco Systems (CSCO).

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $60.30.

Amdocs has a market capitalization of $8.13 billion and generates $4.09 billion in revenue each year. The technology company earns $479.45 million in net income (profit) each year or $4.07 on an earnings per share basis. Amdocs employs 24,516 workers across the globe.

The official website for Amdocs is www.amdocs.com.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]